- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/05 - Epstein-Barr virus
Patent holdings for IPC class C07K 14/05
Total number of patents in this class: 192
10-year publication summary
|
10
|
10
|
13
|
11
|
17
|
13
|
6
|
19
|
10
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3001 |
7 |
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | 381 |
6 |
| National Research Council of Canada | 1551 |
5 |
| Baylor College of Medicine | 1002 |
4 |
| City of Hope | 1030 |
4 |
| The Council of the Queensland Institute of Medical Research | 164 |
4 |
| Dana-Farber Cancer Institute, Inc. | 2664 |
4 |
| Glaxosmithkline Biologicals S.A. | 1602 |
3 |
| The General Hospital Corporation | 4870 |
3 |
| Cancer Research Technology Limited | 514 |
3 |
| Cornell University | 3425 |
3 |
| Deutsches Krebsforschungszentrum | 397 |
3 |
| Les Hopitaux Universitaires de Geneve | 44 |
3 |
| Universite de Geneve | 248 |
3 |
| Tusk Therapeutics Ltd | 31 |
3 |
| Sanofi | 4301 |
3 |
| Centre National de La Recherche Scientifique | 11023 |
2 |
| Amgen Inc. | 4427 |
2 |
| The Board of Trustees of the Leland Stanford Junior University | 6653 |
2 |
| The Trustees of the University of Pennsylvania | 4415 |
2 |
| Other owners | 123 |